Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17345230 | 0.84 | MEN1 (0.45) | POLBSMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL16640993 | 0.83 | CA12 (0.40) | CYP2D6POLBSMN1; SMN2ALDH1A1CA1 | |
| SCHEMBL17051349 | 0.81 | ALDH1A1 (0.35) | CYP2D6ALDH1A1CA1CA2CA7 | |
| SCHEMBL17051338 | 0.80 | ALDH1A1 (0.42) | CYP2D6POLBSMN1; SMN2ALDH1A1CA1 | |
| SCHEMBL17051347 | 0.80 | ALDH1A1 (0.42) | CYP2D6POLBSMN1; SMN2ALDH1A1CA1 | |
| SCHEMBL17051342 | 0.80 | ALDH1A1 (0.42) | CYP2D6POLBSMN1; SMN2ALDH1A1CA1 | |
| SCHEMBL21203079 | 0.80 | MEN1 (0.42) | POLBSMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL17051375 | 0.77 | ALDH1A1 (0.61) | CYP2D6SMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL17366057 | 0.77 | MEN1 (0.39) | POLBSMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL24933345 | 0.76 | CYP2D6 (0.50) | CYP2D6POLBSMN1; SMN2ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725590-B2 | Epoxy compound having alkoxysilyl group, method for preparing the same, composition including the same, cured product made from the composition, and use of the composition | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2017-08-08 | — | — | US | disclosed |
| US-9725590-B2 | Epoxy compound having alkoxysilyl group, method for preparing the same, composition including the same, cured product made from the composition, and use of the composition | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2017-08-08 | — | — | US | disclosed |
| US-20150247033-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD FOR PREPARING THE SAME, COMPOSITION INCLUDING THE SAME, CURED PRODUCT MADE FROM THE COMPOSITION, AND USE OF THE COMPOSITION | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-09-03 | — | — | US | disclosed |
| US-20150247033-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD FOR PREPARING THE SAME, COMPOSITION INCLUDING THE SAME, CURED PRODUCT MADE FROM THE COMPOSITION, AND USE OF THE COMPOSITION | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247033-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD FOR PREPARING THE SAME, COMPOSITION INCLUDING THE SAME, CURED PRODUCT MADE FROM THE COMPOSITION, AND USE OF THE COMPOSITION | ESD, ELL, ALOX5 | CYP2D6 4228/4885POLB 1953/4885SMN1; SMN2 1640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.